Literature DB >> 12901555

Methods of ensuring vaccine safety.

Robert Ball1.   

Abstract

With a decreasing disease burden from vaccine-preventable diseases in developed countries, ensuring the safety of vaccines is critically important for maintaining public confidence in vaccination programs and continuing low levels of disease. This will require investment in resources to identify true adverse effects, understand their pathophysiology, and design and manufacture safer vaccines.

Mesh:

Substances:

Year:  2002        PMID: 12901555     DOI: 10.1586/14760584.1.2.161

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  5 in total

1.  Effects of stratification on data mining in the US Vaccine Adverse Event Reporting System (VAERS).

Authors:  Emily Jane Woo; Robert Ball; Dale R Burwen; M Miles Braun
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Safety surveillance of meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event Reporting System, 2015-2018.

Authors:  Silvia Perez-Vilar; Graça M Dores; Paige L Marquez; Carmen S Ng; Maria V Cano; Anuja Rastogi; Lucia Lee; John R Su; Jonathan Duffy
Journal:  Vaccine       Date:  2021-12-07       Impact factor: 3.641

3.  Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.

Authors:  Pedro L Moro; Silvia Perez-Vilar; Paige Lewis; Marthe Bryant-Genevier; Hajime Kamiya; Maria Cano
Journal:  Pediatrics       Date:  2018-06-04       Impact factor: 7.124

Review 4.  Data mining in the US using the Vaccine Adverse Event Reporting System.

Authors:  John Iskander; Vitali Pool; Weigong Zhou; Roseanne English-Bullard
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

5.  Adverse Events Associated With the Use of Sipuleucel-T Reported to the US Food and Drug Administration's Adverse Event Reporting System, 2010-2017.

Authors:  Graça M Dores; Marthe Bryant-Genevier; Silvia Perez-Vilar
Journal:  JAMA Netw Open       Date:  2019-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.